Literature DB >> 10461456

Photophysical studies of A2-E, putative precursor of lipofuscin, in human retinal pigment epithelial cells.

R Cubeddu1, P Taroni, D N Hu, N Sakai, K Nakanishi, J E Roberts.   

Abstract

With age, human retinal pigment epithelial cells accumulate lipofuscin that can absorb photons in the visible range leading to light-induced damage and impaired vision. A putative precursor of lipofuscin, 2-[2,6-dimethyl-8-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1E,3E, 5E,7E- octatetraenyl]-1-(2-hydroxyethyl)-4-[4-methyl-6-(2,6,6-trimethyl-1 - cyclohexen-1-yl)-1E,3E,5E-hexatrienyl]-pyridinium (A2-E), has recently been isolated and characterized from aged human retinal pigment epithelial cells. We have found that A2-E inhibits the growth of human retinal pigment epithelial cells at concentrations greater than 1 microM. Time-resolved fluorescence measurements of 1 microM A2-E in solution, performed under 413 nm excitation, showed that fluorescence wave forms integrated across the spectrum (450-600 nm) were best-fitted with three decay times in the nanosecond and subnanosecond time scale: 6.6, 1.9 and 0.33 ns. Untreated retinal pigment epithelial cells were characterized by three fluorescence lifetimes: 6.3, 1.7 and 0.35 ns. In retinal pigment epithelial cells treated with 1 microM A2-E, the fluorescence decay was significantly faster, with the marked presence (approximately equal to 30%) of a fourth short lifetime (0.12 ns). These fluorescence decay times for A2-E bound to human retinal pigment epithelial cells are similar to those of lipofuscin granules isolated from aged human retinal pigment epithelial cells. This similarity supports the hypothesis that A2-E is a precursor of lipofuscin and suggests that A2-E may play a role in the overall light damage associated with age-related retinal diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10461456

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  9 in total

Review 1.  Basic investigations for 2-dimensional time-resolved fluorescence measurements at the fundus.

Authors:  D Schweitzer; A Kolb; M Hammer; E Thamm
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

2.  Spectroscopic and morphological studies of human retinal lipofuscin granules.

Authors:  Nicole M Haralampus-Grynaviski; Laura E Lamb; Christine M R Clancy; Christine Skumatz; Janice M Burke; Tadeusz Sarna; John D Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-28       Impact factor: 11.205

3.  [Comparison of parameters of time-resolved autofluorescence between healthy subjects and patients suffering from early AMD].

Authors:  D Schweitzer; S Quick; S Schenke; M Klemm; S Gehlert; M Hammer; S Jentsch; J Fischer
Journal:  Ophthalmologe       Date:  2009-08       Impact factor: 1.059

Review 4.  Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents.

Authors:  Gabriel H Travis; Marcin Golczak; Alexander R Moise; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

Review 5.  [Two-photon fluorescence of ocular melanomas. Studies on a new diagnostic method].

Authors:  M Schneider; K Teuchner; D Leupold
Journal:  Ophthalmologe       Date:  2005-07       Impact factor: 1.059

6.  Adaptive optics two-photon excited fluorescence lifetime imaging ophthalmoscopy of photoreceptors and retinal pigment epithelium in the living non-human primate eye.

Authors:  Sarah Walters; James A Feeks; Khang T Huynh; Jennifer J Hunter
Journal:  Biomed Opt Express       Date:  2021-12-17       Impact factor: 3.562

7.  Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supplementation.

Authors:  Roxana A Radu; Quan Yuan; Jane Hu; Jennifer H Peng; Marcia Lloyd; Steven Nusinowitz; Dean Bok; Gabriel H Travis
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-30       Impact factor: 4.799

8.  Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt's macular degeneration.

Authors:  Roxana A Radu; Nathan L Mata; Aarti Bagla; Gabriel H Travis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

9.  Prospectives for gene therapy of retinal degenerations.

Authors:  Gabriele Thumann
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.